Ventripoint Diagnostics Stock Market Value
| VPTDF Stock | USD 0.09 0 2.67% |
| Symbol | VentriPoint |
VentriPoint Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VentriPoint Diagnostics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VentriPoint Diagnostics.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in VentriPoint Diagnostics on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding VentriPoint Diagnostics or generate 0.0% return on investment in VentriPoint Diagnostics over 90 days. VentriPoint Diagnostics is related to or competes with Sanofi, CSL, GSK Plc, Fresenius, Sonova Holding, Essilor International, and EssilorLuxottica. Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patien... More
VentriPoint Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VentriPoint Diagnostics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess VentriPoint Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.2 | |||
| Information Ratio | 0.0832 | |||
| Maximum Drawdown | 24.13 | |||
| Value At Risk | (8.20) | |||
| Potential Upside | 10.99 |
VentriPoint Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for VentriPoint Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VentriPoint Diagnostics' standard deviation. In reality, there are many statistical measures that can use VentriPoint Diagnostics historical prices to predict the future VentriPoint Diagnostics' volatility.| Risk Adjusted Performance | 0.082 | |||
| Jensen Alpha | 0.5468 | |||
| Total Risk Alpha | 0.2116 | |||
| Sortino Ratio | 0.093 | |||
| Treynor Ratio | (1.09) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VentriPoint Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
VentriPoint Diagnostics February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.082 | |||
| Market Risk Adjusted Performance | (1.08) | |||
| Mean Deviation | 4.5 | |||
| Semi Deviation | 4.7 | |||
| Downside Deviation | 5.2 | |||
| Coefficient Of Variation | 1083.46 | |||
| Standard Deviation | 5.81 | |||
| Variance | 33.74 | |||
| Information Ratio | 0.0832 | |||
| Jensen Alpha | 0.5468 | |||
| Total Risk Alpha | 0.2116 | |||
| Sortino Ratio | 0.093 | |||
| Treynor Ratio | (1.09) | |||
| Maximum Drawdown | 24.13 | |||
| Value At Risk | (8.20) | |||
| Potential Upside | 10.99 | |||
| Downside Variance | 27.0 | |||
| Semi Variance | 22.08 | |||
| Expected Short fall | (5.48) | |||
| Skewness | 0.3366 | |||
| Kurtosis | (0.28) |
VentriPoint Diagnostics Backtested Returns
VentriPoint Diagnostics appears to be out of control, given 3 months investment horizon. VentriPoint Diagnostics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14 % return per unit of risk over the last 3 months. By inspecting VentriPoint Diagnostics' technical indicators, you can evaluate if the expected return of 0.81% is justified by implied risk. Please review VentriPoint Diagnostics' Risk Adjusted Performance of 0.082, semi deviation of 4.7, and Coefficient Of Variation of 1083.46 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, VentriPoint Diagnostics holds a performance score of 10. The entity has a beta of -0.48, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning VentriPoint Diagnostics are expected to decrease at a much lower rate. During the bear market, VentriPoint Diagnostics is likely to outperform the market. Please check VentriPoint Diagnostics' maximum drawdown and the relationship between the semi variance and day typical price , to make a quick decision on whether VentriPoint Diagnostics' existing price patterns will revert.
Auto-correlation | -0.5 |
Modest reverse predictability
VentriPoint Diagnostics has modest reverse predictability. Overlapping area represents the amount of predictability between VentriPoint Diagnostics time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VentriPoint Diagnostics price movement. The serial correlation of -0.5 indicates that about 50.0% of current VentriPoint Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.5 | |
| Spearman Rank Test | -0.49 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in VentriPoint Pink Sheet
VentriPoint Diagnostics financial ratios help investors to determine whether VentriPoint Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VentriPoint with respect to the benefits of owning VentriPoint Diagnostics security.